All news
Unblocking Multinational Clinical Trials in Europe: Progress, but More to Do
18 April 2026New Clinical Trials Regulation guidance from the European Commission introduces an Article 11 workaround to ease trial delays. While improving mult...
When a Parent Has Cancer: How to Talk to Your Children, Honestly and Gently
16 April 2026Telling a child you have cancer is never easy. This practical guide helps families navigate the conversation with honesty, reassurance, and care—...
Investing in Impact: DiCE Supports Member Organisations through ECCAM Grants
27 March 2026This spring, DiCE dedicated its first 2026 grant round to ECCAM, supporting 11 Member Organisations with funding between €1,000 and €1,500. A s...
Patents, Prices, and Patients: a Global Campaign Putting Access to Medicines Under the Spotlight
27 March 2026New global campaign Patients and Patents highlights how pharmaceutical patent practices affect access to affordable medicines. With clear tools and...
A Turning Point Before Surgery: CASSANDRA Redefines Neoadjuvant Therapy in Pancreatic Cancer
26 March 2026The CASSANDRA phase III trial shows that the PAXG regimen significantly improves outcomes over mFOLFIRINOX in resectable pancreatic cancer. This pa...
Europe Approves First-line Immunotherapy for Advanced Anal Cancer
26 March 2026New progress for advanced anal cancer in Europe. The European Commission has approved retifanlimab with chemotherapy as a first-line treatment, hel...
BATTMAN Trial Targets Breakthrough in Hard-to-Treat Colorectal Cancer
26 March 2026A new Phase III trial, BATTMAN, explores combination immunotherapy for MSS metastatic colorectal cancer, a group with limited options. By targeting...
Growing Stronger Together: DiCE Welcomes Four New Member Organisations
18 February 2026Digestive Cancers Europe (DiCE) is proud to welcome four new member organisations, further strengthening its network of patient advocates and partn...
Breakthroughs, Reality Checks, and New Directions in HBP Cancer Care
18 February 2026The annual American Society of Clinical Oncology – Gastrointestinal (ASCO-GI) meeting highlighted a major shift in treating Hepato-Bilio-Panc...
Expanding the Biomarker Landscape on Gastric Cancer
17 February 2026New research presented at the 2026 ASCO GI meeting shows that understanding the biology of gastric and gastroesophageal cancers is driving more per...